ALNY vs UVSP · P/E 76, rev $1.29B vs P/E 12, rev $171.8M
Alnylam Pharmaceuticals Inc (ALNY) versus Univest Corporation Pennsylvania (UVSP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Univest Corporation Pennsylvania (UVSP) is a banks - regional company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported UVSP revenue for 2026-06-30 was $171.8M. Net income was $50.0M. Revenue was up 96.5% from 2026-03-31 to 2026-06-30. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
Not investment advice. Open the ALNY and UVSP stock pages for the full models.
Not investment advice.